Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2025 08:00 ET | Source: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Partnership supports near-term launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, June 23, 2025 (GLOBE NEWSWIRE) -- Jupiter...
June 09, 2025 07:00 ET | Source: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science

First consumer products roll out in Q3 2025, creating near-term revenue potential and marking a new chapter in Jupiter's evolution Jupiter, Florida, June 09, 2025 (GLOBE NEWSWIRE) -- Jupiter...
October 04, 2021 08:00 ET | Source: Certara

Certara Completes Acquisition of Pinnacle 21

PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire...
September 22, 2021 08:00 ET | Source: Certara

Certara Announces New Clinical Science Group and Adds Senior Scientific Experts

PRINCETON, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that it is expanding its Integrated Drug Development (IDD) division with a new clinical...
June 11, 2021 03:00 ET | Source: Novartis Pharma AG

Novartis investigational oral therapy iptacopan (LNP023) shows benefit as monotherapy in treatment-naïve patients with rare and life-threatening blood disorder paroxysmal nocturnal hemoglobinuria

First-in-class, oral, targeted factor B inhibitor iptacopan substantially reduced both intra- and extravascular hemolysis when given as monotherapy in a Phase II study of anti-C5 naïve paroxysmal...
May 22, 2018 16:32 ET | Source: Trivedi Global, Inc.

Trivedi Global, Inc. and Dr. William Plikerd Announce Results on the Impact of a Biofield Treated Proprietary Formulation to Combat Autoimmune and Inflammatory Disorders

Columbus, OH, USA, May 22, 2018 (GLOBE NEWSWIRE) -- Dr. William Plikerd, an evidence-based healer today announces research results on the significant impact of a proprietary biofield energy healing...
May 22, 2018 13:38 ET | Source: Trivedi Global, Inc.

Trivedi Global, Inc. in Association with Victoria Vannes Announces Research Results on an Energy Infused Proprietary Product to Combat Inflammation and Autoimmune Disorders

Philadelphia, Pennsylvania. U.S.A., May 22, 2018 (GLOBE NEWSWIRE) -- Victoria Vannes, an evidence-based healer today announces research results on the significant impact of a proprietary biofield...